Comment on: A Systematic Review and Meta-Analyses of the Association Between Anti-hypertensive Classes and the Risk of Falls Among Older Adults

In their article, the authors conclude that there is a decreased risk of injurious falls associated with the use of angiotensin-converting enzyme inhibitors (ACEis), ß-blockers (BBs) or calcium channel blockers (CCBs), and no association with falls and recurrent falls. [...]there has been a recent focus on the dynamic nature of the risk profile of fall risk-increasing drugs (FRIDs) [6-10]. For diuretics, the OR remained significantly elevated until day 21. [...]strategies to reduce falling are warranted when antihypertensive medications are commenced in older adults, due to an increased falls risk during the initial period of therapy.